THYMIC CARCINOMAS DIAGNOSED AT THE PATHOLOGY DEPARTMENT AT JRA HOSPITAL

Authors

  • Raivoherivony Department of Pathology , Joseph Ravoahangy Andrianavalona University Hospital, Antananrivo
  • Rabarijaona Department of Pathology, Joseph Ravoahangy Andrianavalona University Hospital, Antananarivo Madagascar
  • Ranaivoson Department of Pathology, Joseph Ravoahangy Andrianavalona University Hospital, Antananarivo Madagascar
  • Randrianjafisamindrakotroka Chairman of the Department of Pathology, Medical School of Antananarivo, Antananarivo, Madagascar

DOI:

https://doi.org/10.53555/bp.v8i12.2121

Keywords:

Carcinoma, Madagascar, Thymus, Thymic Epithelial Tumour

Abstract

INTRODUCTION

Thymic epithelial tumours are rare pathologies but represent 20% of mediastinum tumours [1] and are the first cause of anterior mediastinal mass (35 to 50% of cases). According to World Health Organization (WHO) classification in 2004, thymic epithelial tumors are divided on three types: thymomas (80% of cases), thymic carcinomas and neuroendocrine tumours (5%) [2, 3]. Thymic carcinomas have an incidence of 0.2 to 0.5 per million people [4]. Itrepresent 5% of all malignant thymic tumours and 15% of thymic epithelial tumours. These are aggressive tumours [1, 5]. The overall survival rate at 5 years is about 30 to 50%, and it is less than 20% between 5 and 10 years [6, 7]. The aim of our study is to describe the epidemiological and histopathologicalfeatures of thymic carcinomas, diagnosed at the Pathology Department, with a review of the literature.

 

Materials and method

This is a retrospective and descriptive study of thymic carcinomas diagnosed at the Pathology Departmentat JRAUniversity Hospital, during 10 years from January 2010 to December 2019.

 

Downloads

Download data is not yet available.

References

PA Thomas, MJ Payan-Defais. (2010) Tumeurs épithéliales thymiques. Revue de Pneumologie clinique ; 66 : 41—51.

Marx A, Ströbel P, Badve SS. (2014) ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J ThoracOncol; 9:596–611.

Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. World Health Organization Classification of Tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart. (eds.), Lyon: International Agency for Research on Cancer (IARC) Press; 2004.

Girard N, Maury JM, Chalabreysse L, Besse B, Rythmic .(2016) Tumeursthymiques. EMC – Pneumologie;13(3):1-15

Giuseppe Giaccone, Chul Kim, Jillian Thompson, Colleen McGuire, BhaskarKallakury, Joeffrey J Chahine, et al. (2018) Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study. Lancet Oncol; 19: 347–55

Yu Yang, Xing-Wen Fan, Hong-Bing Wang, Yin Xu, Dou-Dou Li, Kai-Liang Wu. (2017) Stage IVbthymic carcinoma: patients with lymph node metastases have better prognoses than those with hematogenous metastases. BMC Cancer 17:217

Chun-Hsiang Hsu, Chan JK, Yin C-H, Lee C-C, Chern C-U, Liao C-I. (2019) Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States. PLoS ONE, 14(12): 1-13

C. Le Péchoux, M. Mahé, J.-J. Bretel, E. Roberti, P. Ruffié. (2005) Tumeurs épithéliales thymiques. Cancer/Radiothérapie 9 351–357

S. Suster, J. Rosai. ThymicCarcinom. (1991) AClinicopathologic Study of 60 Cases. CANCER ; 67 : 1025-1032.

A. Ayadi-Kaddoura, D. Bachaa, B. Smatib, T. Kilani, F. El Mezni. (2009) Carcinomes thymiques primitifs : à propos de trois cas avec revue de la littérature. Revue de Pneumologie clinique65, 113—117.

Cesar A. Moran, Saul Suster. ((2008)) Thymic Carcinoma: Current Concepts and Histologic Features. HematolOncolClin N Am 22 393–407

Marx A, Rieker R, Toker A, Langer F, Strobel P. (2011) Thymic carcinoma: is it a separate entity? From molecular to clinical evidence. ThoracSurgClin.; 21:25–31.

Ricardo V. Lloyd, Lori A. Erickson. (2015) Neuroendocrine and Paracrine Systems. inSternberg’s Diagnostic Surgical Pathology. Sixth Edition. Wolters Kluwer; 1871 – 78.

Wolfgang Jungraithmayr, Didier Schneiter, Alex Soltermann, Thomas Frauenfelder, Walter Weder.(2016) Diagnostic et traitement du carcinome thymique Forum Médical Suisse;16(47):1019–1025

Lara Chalabreysse, Vincent Thomas De Montpreville, Anne De Muret, Véronique Hofman, Sylvie Lantuejoul et al. (2014) Rythmic-Pathologie : le groupe français de relecture des tumeurs épithéliales thymiques du réseau clinique Rythmic. Annales de pathologie ; 34 : 87—91.

W. Jacot, X. Quantin, J.-L. Pujol. (2006) Treatment of epithelial thymictumours: towards a multidisciplinary management. Rev Mal Respir; 23 : 3S35-3S46

Weissferdt A, Moran CA. (2014) Immunohistochemistry in the Diagnosis of Thymic Epithelial Neoplasms. ApplImmunohistochemMolMorphol; 22:479–87.

Downloads

Published

2022-12-28

How to Cite

Raivoherivony, Z. I., Rabarijaona, . R. H. N., Ranaivoson, H. V. R., & Randrianjafisamindrakotroka, N. S. (2022). THYMIC CARCINOMAS DIAGNOSED AT THE PATHOLOGY DEPARTMENT AT JRA HOSPITAL. International Journal For Research In Biology & Pharmacy, 8(12), 5–8. https://doi.org/10.53555/bp.v8i12.2121

Most read articles by the same author(s)

<< < 1 2